Shares of Advanced Micro Devices (NASDAQ: AMD) and Micron Technology (NASDAQ: MU) are trading at steep discounts, while these ...

The gross proceeds from the offering, before deducting the underwriting discounts and commissions and offering expenses payable by Outlook Therapeutics are expected to be approximately $13.0 million.

BTIG, LLC is acting as sole book-running manager for the offering.

The chipmaker recently reached a partnership with Saudi Arabian AI startup Humain to help build a $10 billion AI-computing ...

The three major microchip stocks in this analysis are all quiet in premarket trading on Tuesday, as the market continues to ...

Shares of Advanced Micro Devices (NASDAQ:AMD) have bounced back nicely since hitting their year-to-date low of $78.21 on ...

AMD's MI300X data center GPU is the company's top AI chip, and it won over many of Nvidia's top customers, including ...

The networking giant’s stock rallied after the company issued a solid forecast for revenue in the current quarter, exceeding ...

"The buy-the-dip strategy in early April has clearly paid off," said a team of JPMorgan strategists led by Emma Wu. "We estimate retail investors' portfolio is up 15.1% since April 8, closely aligning ...

The premarket trading in the three stocks featured here are all seeing a bit of selling, but only slightly so. At this point ...

This article will examine how the chipmakers compare in terms of Quant Factor Grades and how TSM’s more compelling valuation ...

A tech rally helped push the Nasdaq higher, with shares of AMD and Nvidia rising more than 4%. Alphabet (GOOGL, GOOG) ticked ...